AMLOZAAR

This brand name is authorized in Nigeria.

Active ingredients

The drug AMLOZAAR contains a combination of these active pharmaceutical ingredients (APIs):

1	Amlodipine UNII 864V2Q084H - AMLODIPINE BESYLATE
	Amlodipine is a calcium ion influx inhibitor of the dihydropyridine group (slow channel blocker or calcium ion antagonist) and inhibits the transmembrane influx of calcium ions into cardiac and vascular smooth muscle.
	Read more about Amlodipine
2	Losartan UNII 3ST302B24A - LOSARTAN POTASSIUM
	Losartan is a synthetic oral angiotensin-II receptor (type AT1) antagonist. Antihypertensive activity and suppression of plasma aldosterone concentration are maintained, indicating effective angiotensin II receptor blockade.
	Read more about Losartan

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
A4-8425	Tablet	Amlozaar Tablets TAB 5 mg; 50 mg 3 x 10's (in Alu-Alu blisters)	Film coated tablet. Light Yellow coloured, circular biconvex film-coated tablets with ‘MICRO’ engraved on both sides	25/02/2021

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09DB06	Losartan and amlodipine	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09D Angiotensin II antagonists, combinations → C09DB Angiotensin II antagonists and calcium channel blockers
Discover more medicines within C09DB06

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	A4-8425